Summary

Medical genetics is the discipline that examines how variation in our DNA underlies health and disease. It spans rare, highly penetrant single-gene disorders and the more complex, multifactorial conditions that arise from the interplay of multiple genes, environmental exposures and lifestyle. Advances in sequencing technologies and high-throughput assays have transformed diagnosis, risk stratification and treatment, moving medical practice towards precision medicine. Today, genetic testing can confirm inherited syndromes in infancy, identify carriers and guide reproductive decisions, predict adverse drug reactions through pharmacogenomics and uncover polygenic risk scores for common diseases such as diabetes, cardiovascular disease and neuropsychiatric disorders. Coupled with functional studies—from cell models to organoids and animal gene-therapy experiments—medical genetics delivers new insights into disease mechanisms and enables tailored interventions, prophylactic strategies and gene-based therapies that promise to improve outcomes across the lifespan.

Research from Nature Portfolio

In a preclinical gene-therapy breakthrough, delivery of a single hepatocyte-specific rAAV8 vector encoding human lysosomal acid lipase completely reversed multisystem lipid storage and restored mitochondrial function in a murine model of lysosomal acid lipase deficiency, suggesting a one-time curative approach that outperforms lifelong enzyme replacement. A multiomics investigation integrated MRI-quantified liver fat in over 45 000 individuals with genome-wide association, transcriptomic and proteomic data to identify 18 common variants influencing steatosis and four linked to cirrhosis. Rare loss-of-function alleles in MTARC1 and GPAM emerged as protective, highlighting new drug targets, and plasma protein signatures distinguished early fatty liver from advanced disease. In the realm of precision diabetes medicine, an international consensus outlined evidence gaps and clinical opportunities across monogenic, gestational, type 1 and type 2 diabetes, charting standards for genetic readiness, cost-effectiveness and equitable implementation as genomic testing becomes integral to diagnosis, therapy choice and complication prevention.

Medical Genetics publication trend

The graph below shows the total number of articles in medical genetics across all publications each year (not limited to Nature Index journals).

Technical terms

Monogenic disorder: A disease caused by mutations in a single gene, often with high penetrance and predictable inheritance patterns.

Polygenic risk score: A composite measure of an individual’s genetic predisposition to a trait or disease, calculated from the sum of multiple risk-associated variants.

Pharmacogenomics: The study of how genetic variation influences drug metabolism, efficacy and toxicity to guide personalised prescribing.

rAAV vector: A recombinant adeno-associated virus engineered to deliver therapeutic genes to target cells for long-term expression.

Organotypic model: An in vitro three-dimensional culture that recapitulates key structural and functional features of a tissue to study disease mechanisms and drug responses.

Loss-of-function allele: A genetic variant that abolishes or significantly reduces the activity of the encoded protein.

Consensus guidelines: Evidence-based recommendations developed by expert panels to standardise clinical application of genetic and precision-medicine advances.

References

  1. Medical Genetics.
  2. Rescue of lysosomal acid lipase deficiency in mice by rAAV8 liver gene transfer. Communications Medicine (2025).
  3. Multiomics study of nonalcoholic fatty liver disease. Nature Genetics (2022).
  4. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. Nature Medicine (2023).
  5. Human genes influence the interaction between Streptococcus mutans and host caries susceptibility: a genome-wide association study in children with primary dentition. International Journal of Oral Science (2019).
  6. Pharmacogenomic insights in psychiatric care: uncovering novel actionability, allele-specific CYP2D6 copy number variation, and phenoconversion in 15,000 patients. Molecular Psychiatry (2024).
  7. Proteomic analysis reveals potential therapeutic targets for childhood asthma through Mendelian randomization. Clinical and Translational Allergy (2024).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.